PLRX
NASDAQ · Pharmaceuticals
Pliant Therapeutics Inc
$1.20
-0.02 (-1.64%)
Open$1.22
Previous Close$1.22
Day High$1.23
Day Low$1.19
52W High$1.95
52W Low$1.09
Volume—
Avg Volume379.7K
Market Cap76.77M
P/E Ratio—
EPS$-3.39
SectorPharmaceuticals
Analyst Ratings
Sell
11 analysts
Price Target
+1,323.3% upside
Current
$1.20
$1.20
Target
$17.08
$17.08
$13.48
$17.08 avg
$25.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.16M | 13.79M | 14.54M |
| Net Income | 3.08M | 2.65M | 3.08M |
| Profit Margin | 20.3% | 19.2% | 21.2% |
| EBITDA | 5.59M | 4.59M | 4.96M |
| Free Cash Flow | 2.06M | 2.45M | 2.36M |
| Rev Growth | +19.0% | -9.0% | -2.1% |
| Debt/Equity | 0.34 | 0.31 | 0.34 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |